Freenome
Freenome, Walgreens Partner to Diversify Cancer Early Detection Studies
The pharmacy firm will lend its recruitment technology and infrastructure to enroll a more diverse patient population, beginning with Freenome's Sanderson Study.
In Brief This Week: Mainz Biomed, Centogene, DermTech, Freenome, Ginkgo Biotech, More
News items for the week of April 10, 2023.
In Brief This Week: Interpace Biosciences, ProPhase Labs, OpGen, Centogene, Seegene, Freenome, More
News items for the week of March 27, 2023.
Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study
The Pennsylvania health system will be able to access patients in both urban and rural settings, aiding Freenome's goal to recruit a total of 8,000 individuals.
Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence
The company plans to analyze both traditional and real-world data from about 8,000 individuals to validate and optimize its multi-cancer early detection platform.
Jan 11, 2022
Freenome Nets $290M Investment From Roche
Dec 7, 2021
Freenome Raises $300M in Series D Financing
Sep 30, 2021
May 28, 2020
Aug 29, 2019
Jul 24, 2019
Freenome Closes $160M Series B Financing Round
Apr 1, 2019